Indonesia Energy Corporation Limited vs Oscar Health Inc — how do they compare? Indonesia Energy Corporation Limited trades at $2.74 (market cap $43.24M), while Oscar Health Inc trades at $33.37 (market cap $10.22B). The key difference: Oscar Health Inc is far larger — about 236.4× Indonesia Energy Corporation Limited's market cap, and Oscar Health Inc is trading nearer its 52-week high, Indonesia Energy Corporation Limited nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Indonesia Energy Corporation Limited for 24 Days and Oscar Health Inc for 15 Days on average.
| INDO | OSCR | |
|---|---|---|
Market Cap | $43.24M | $10.22B |
Volume | 116,953 | 4,123,394 |
Sector | Energy | Health |
52-Week High | $6.74 | $33.81 |
52-Week Low | $2.49 | $10.85 |
Typical Hold Time | 24 Days | 15 Days |
Enterprise Value | $38.18M | $6.57B |
Signals from Pluang's Aura AI — not financial advice
INDO trades at $2.81, up 1.44% on the day, but exhibits a bearish technical signal with negative profitability metrics including a net income margin of -152.72% and ROE of -19.77% for 2025. Recent news highlights operational progress with the K-29 oil well discovery and production commencement, though financial results remain deeply negative. The stock's price-to-sales ratio is elevated at 15.2, and cash flow from operations is negative at -$5.43M, offset by financing inflows.
The outlook is speculative, hinging on successful production scaling from new wells to reverse persistent losses. Investment opportunity lies in potential revenue growth from oil operations, but risks include high cash burn, negative margins, and execution challenges in a volatile energy market. Analyst consensus is unanimously bullish with 3 buy ratings, suggesting optimism on future turnaround.
OSCR trades at $33.1, up 0.58% on the day, with a bullish technical signal from moving averages. The company reported strong Q1 and Q2 2026 earnings beats, with revenue growth from $11.7B in 2025 to a projected $15.3B in 2026, turning to a net profit. Analyst consensus is a $34 price target, with 31% buy ratings. Recent news highlights market share gains and raised 2026 guidance following its Investor Day.
The outlook is positive, driven by execution in the ACA market and new growth avenues, but risks include rising medical costs threatening profitability and a high P/E ratio. The stock offers growth potential if margin expansion continues as guided.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Indonesia Energy is an oil and gas exploration and production company. It focuses on identifying and developing energy resources in Indonesia, primarily through its Kruh and Citarum blocks.
Read more on INDO →Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →